Article actualité
Plus d'articles...
- CARMAT publie ses résultats semestriels 2022
- NH TherAguix announces the arrival of Dr. Olivier de Beaumont as Chief Medical Officer
- Neuroplast receives second orphan medicinal product designation for Neuro-Cells®, paving the way for application to both chronic and trauma-induced neurodegenerative diseases
- Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with Stress Urinary Incontinence using a Novel Regenerative Cell Therapy